Acadia (ACHC) Should Be Bought on CMA Enforcement Order Weakness - Mizuho

Go back to Acadia (ACHC) Should Be Bought on CMA Enforcement Order Weakness - Mizuho

Acadia Healthcare (ACHC) PT, Estimates Cut at Jefferies

February 17, 2016 6:51 AM EST

Jefferies analyst Brian Tanquilut lowered his price target on Acadia Healthcare (NASDAQ: ACHC) to $85.00 (from $100.00) but maintained a Buy rating.

Tanquilut commented, "Our thesis on ACHC (strong organic growth boosted by M&A, with optionality for Medicaid-driven upside) was further validated by... More

Acadia Healthcare (ACHC) Reports In-Line Q4 EPS, Offers Q1 & FY Guidance

February 16, 2016 4:14 PM EST

Acadia Healthcare (NASDAQ: ACHC) reported Q4 EPS of $0.59, in-line with the analyst estimate of $0.59. Revenue for the quarter came in at $495.3 million versus the consensus estimate of $488 million.

GUIDANCE:

Acadia Healthcare sees Q1 2016 EPS of $0.53-$0.54, versus the consensus of... More